BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Serhan CN. A search for endogenous mechanisms of anti-inflammation uncovers novel chemical mediators: missing links to resolution. Histochem Cell Biol 2004;122:305-21. [PMID: 15322859 DOI: 10.1007/s00418-004-0695-8] [Cited by in Crossref: 110] [Cited by in F6Publishing: 107] [Article Influence: 6.1] [Reference Citation Analysis]
Number Citing Articles
1 Steffens JP, Herrera BS, Coimbra LS, Stephens DN, Rossa C Jr, Spolidorio LC, Kantarci A, Van Dyke TE. Testosterone regulates bone response to inflammation. Horm Metab Res 2014;46:193-200. [PMID: 24526374 DOI: 10.1055/s-0034-1367031] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
2 Macdonald LJ, Boddy SC, Denison FC, Sales KJ, Jabbour HN. A role for lipoxin A₄ as an anti-inflammatory mediator in the human endometrium. Reproduction 2011;142:345-52. [PMID: 21555360 DOI: 10.1530/REP-11-0021] [Cited by in Crossref: 41] [Cited by in F6Publishing: 18] [Article Influence: 3.7] [Reference Citation Analysis]
3 Hyde CA, Missailidis S. Inhibition of arachidonic acid metabolism and its implication on cell proliferation and tumour-angiogenesis. Int Immunopharmacol 2009;9:701-15. [PMID: 19239926 DOI: 10.1016/j.intimp.2009.02.003] [Cited by in Crossref: 98] [Cited by in F6Publishing: 91] [Article Influence: 7.5] [Reference Citation Analysis]
4 Gulati M, Anand V, Govila V, Jain N. Host modulation therapy: An indispensable part of perioceutics. J Indian Soc Periodontol 2014;18:282-8. [PMID: 25024538 DOI: 10.4103/0972-124X.134559] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
5 Ramos GC, Fernandes D, Charão CT, Souza DG, Teixeira MM, Assreuy J. Apoptotic mimicry: phosphatidylserine liposomes reduce inflammation through activation of peroxisome proliferator-activated receptors (PPARs) in vivo. Br J Pharmacol 2007;151:844-50. [PMID: 17533418 DOI: 10.1038/sj.bjp.0707302] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 3.3] [Reference Citation Analysis]
6 Cekici A, Kantarci A, Hasturk H, Van Dyke TE. Inflammatory and immune pathways in the pathogenesis of periodontal disease. Periodontol 2000. 2014;64:57-80. [PMID: 24320956 DOI: 10.1111/prd.12002] [Cited by in Crossref: 417] [Cited by in F6Publishing: 400] [Article Influence: 59.6] [Reference Citation Analysis]
7 Lipa M, Bomba-Opoń D, Lipa J, Bartnik P, Bartoszewicz Z, Wielgoś M. Lipoxin A4 (LXA4) as a potential first trimester biochemical marker of intrauterine growth disorders. J Matern Fetal Neonatal Med 2017;30:2495-7. [PMID: 27819165 DOI: 10.1080/14767058.2016.1254182] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
8 Farooqui AA, Horrocks LA, Farooqui T. Modulation of inflammation in brain: a matter of fat. J Neurochem. 2007;101:577-599. [PMID: 17257165 DOI: 10.1111/j.1471-4159.2006.04371.x] [Cited by in Crossref: 309] [Cited by in F6Publishing: 238] [Article Influence: 20.6] [Reference Citation Analysis]
9 Lolli ML, Giorgis M, Tosco P, Foti A, Fruttero R, Gasco A. New inhibitors of dihydroorotate dehydrogenase (DHODH) based on the 4-hydroxy-1,2,5-oxadiazol-3-yl (hydroxyfurazanyl) scaffold. European Journal of Medicinal Chemistry 2012;49:102-9. [DOI: 10.1016/j.ejmech.2011.12.038] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
10 Zhao S, Liao T, Zhou T, Huang X, Xiang H, Chen J, Xu Z. Formyl-peptide receptor 2 suppresses proliferation, migration and invasion in human extravillous trophoblastic cells. Prostaglandins & Other Lipid Mediators 2019;143:106342. [DOI: 10.1016/j.prostaglandins.2019.106342] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Spite M, Serhan CN. Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins. Circ Res 2010;107:1170-84. [PMID: 21071715 DOI: 10.1161/CIRCRESAHA.110.223883] [Cited by in Crossref: 266] [Cited by in F6Publishing: 133] [Article Influence: 22.2] [Reference Citation Analysis]
12 Kantarci A, Van Dyke TE. Lipoxin signaling in neutrophils and their role in periodontal disease. Prostaglandins Leukot Essent Fatty Acids 2005;73:289-99. [PMID: 15979867 DOI: 10.1016/j.plefa.2005.05.019] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
13 Kantarci A, Van Dyke TE. Resolution of inflammation in periodontitis. J Periodontol 2005;76:2168-74. [PMID: 16277590 DOI: 10.1902/jop.2005.76.11-S.2168] [Cited by in Crossref: 34] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
14 Hromcik F, Vokurka J, Gopfert E, Faldyna M, Hermanova M, Kyr M, Vicenova M, Izakovicova Holla L. Granulation tissue enriched by aspirin and omega-3 fatty acids in healing experimental periodontal lesion. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2021;165:216-23. [PMID: 32091012 DOI: 10.5507/bp.2020.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Recchiuti A. Resolvin D1 and its GPCRs in resolution circuits of inflammation. Prostaglandins & Other Lipid Mediators 2013;107:64-76. [DOI: 10.1016/j.prostaglandins.2013.02.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
16 Spite M, Clària J, Serhan CN. Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases. Cell Metab 2014;19:21-36. [PMID: 24239568 DOI: 10.1016/j.cmet.2013.10.006] [Cited by in Crossref: 261] [Cited by in F6Publishing: 247] [Article Influence: 29.0] [Reference Citation Analysis]
17 Asan E, Drenckhahn D. News and views in Histochemistry and Cell Biology. Histochem Cell Biol 2004;122:593-621. [PMID: 15614519 DOI: 10.1007/s00418-004-0735-4] [Reference Citation Analysis]
18 Lannan KL, Spinelli SL, Blumberg N, Phipps RP. Maresin 1 induces a novel pro-resolving phenotype in human platelets. J Thromb Haemost 2017;15:802-13. [PMID: 28079976 DOI: 10.1111/jth.13620] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
19 Kunes P, Mandak J, Holubcova Z, Kolackova M, Krejsek J. The long pentraxin PTX3: a candidate anti-inflammatory mediator in cardiac surgery. Perfusion 2013;28:377-89. [DOI: 10.1177/0267659113483799] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
20 Zahoor I, Giri S. Specialized Pro-Resolving Lipid Mediators: Emerging Therapeutic Candidates for Multiple Sclerosis. Clin Rev Allergy Immunol 2021;60:147-63. [PMID: 32495237 DOI: 10.1007/s12016-020-08796-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
21 Ji RR, Xu ZZ, Strichartz G, Serhan CN. Emerging roles of resolvins in the resolution of inflammation and pain. Trends Neurosci 2011;34:599-609. [PMID: 21963090 DOI: 10.1016/j.tins.2011.08.005] [Cited by in Crossref: 207] [Cited by in F6Publishing: 198] [Article Influence: 18.8] [Reference Citation Analysis]
22 Ogawa N, Kobayashi Y. Total synthesis of the antiinflammatory and proresolving protectin D1. Tetrahedron Letters 2011;52:3001-4. [DOI: 10.1016/j.tetlet.2011.03.152] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
23 Serhan CN, Chiang N, Dalli J. New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration. Mol Aspects Med 2018;64:1-17. [PMID: 28802833 DOI: 10.1016/j.mam.2017.08.002] [Cited by in Crossref: 92] [Cited by in F6Publishing: 106] [Article Influence: 18.4] [Reference Citation Analysis]
24 Sitkovsky MV, Ohta A. The 'danger' sensors that STOP the immune response: the A2 adenosine receptors? Trends Immunol. 2005;26:299-304. [PMID: 15922945 DOI: 10.1016/j.it.2005.04.004] [Cited by in Crossref: 192] [Cited by in F6Publishing: 187] [Article Influence: 11.3] [Reference Citation Analysis]
25 Serhan CN. Novel chemical mediators in the resolution of inflammation: resolvins and protectins. Anesthesiol Clin 2006;24:341-64. [PMID: 16927933 DOI: 10.1016/j.atc.2006.01.003] [Cited by in Crossref: 74] [Cited by in F6Publishing: 63] [Article Influence: 4.6] [Reference Citation Analysis]
26 Lim S, Huang W, Hall JC, Michael-titus AT, Priestley JV. Improved outcome after spinal cord compression injury in mice treated with docosahexaenoic acid. Experimental Neurology 2013;239:13-27. [DOI: 10.1016/j.expneurol.2012.09.015] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 4.2] [Reference Citation Analysis]
27 Araki M, Matsubara T, Abe H, Torikoshi K, Mima A, Iehara N, Fukatsu A, Kita T, Arai H, Doi T. Conditional Deletion of Smad1 Ameliorates Glomerular Injury in Progressive Glomerulonephritis. Sci Rep 2016;6:31216. [PMID: 27492138 DOI: 10.1038/srep31216] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
28 Serhan CN. Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and pharmacology. Mol Aspects Med 2017;58:1-11. [PMID: 28263773 DOI: 10.1016/j.mam.2017.03.001] [Cited by in Crossref: 103] [Cited by in F6Publishing: 93] [Article Influence: 20.6] [Reference Citation Analysis]
29 Serhan CN, Chiang N. Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus. Br J Pharmacol. 2008;153 Suppl 1:S200-S215. [PMID: 17965751 DOI: 10.1038/sj.bjp.0707489] [Cited by in Crossref: 217] [Cited by in F6Publishing: 235] [Article Influence: 14.5] [Reference Citation Analysis]
30 Maderna P, Godson C. Taking insult from injury: lipoxins and lipoxin receptor agonists and phagocytosis of apoptotic cells. Prostaglandins Leukot Essent Fatty Acids 2005;73:179-87. [PMID: 15978792 DOI: 10.1016/j.plefa.2005.05.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
31 Petasis NA, Akritopoulou-Zanze I, Fokin VV, Bernasconi G, Keledjian R, Yang R, Uddin J, Nagulapalli KC, Serhan CN. Design, synthesis and bioactions of novel stable mimetics of lipoxins and aspirin-triggered lipoxins. Prostaglandins Leukot Essent Fatty Acids 2005;73:301-21. [PMID: 16098719 DOI: 10.1016/j.plefa.2005.05.020] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 2.6] [Reference Citation Analysis]
32 Karatay E, Utku ÖG. Serum resolvin D1 levels as a marker of inflammation in constipation dominant irritable bowel syndrome. Turk J Gastroenterol 2020;31:113-9. [PMID: 32141819 DOI: 10.5152/tjg.2020.19751] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
33 Iglicki M, Loewenstein A, Barak A, Schwartz S, Zur D. Outer retinal hyperreflective deposits (ORYD): a new OCT feature in naïve diabetic macular oedema after PPV with ILM peeling. Br J Ophthalmol 2020;104:666-71. [PMID: 31391181 DOI: 10.1136/bjophthalmol-2019-314523] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
34 Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol. 2008;8:349-361. [PMID: 18437155 DOI: 10.1038/nri2294] [Cited by in Crossref: 1820] [Cited by in F6Publishing: 1699] [Article Influence: 130.0] [Reference Citation Analysis]
35 Umrania VV, Rao Deepika PC, Kulkarni M. Evaluation of dietary supplementation of omega-3 polyunsaturated fatty acids as an adjunct to scaling and root planing on salivary interleukin-1β levels in patients with chronic periodontitis: A clinico-immunological study. J Indian Soc Periodontol 2017;21:386-90. [PMID: 29491585 DOI: 10.4103/jisp.jisp_16_16] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
36 Chattopadhyay R, Mani AM, Singh NK, Rao GN. Resolvin D1 blocks H2O2-mediated inhibitory crosstalk between SHP2 and PP2A and suppresses endothelial-monocyte interactions. Free Radic Biol Med 2018;117:119-31. [PMID: 29408202 DOI: 10.1016/j.freeradbiomed.2018.01.034] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
37 Hasturk H, Kantarci A, Van Dyke TE. Oral inflammatory diseases and systemic inflammation: role of the macrophage. Front Immunol 2012;3:118. [PMID: 22623923 DOI: 10.3389/fimmu.2012.00118] [Cited by in Crossref: 79] [Cited by in F6Publishing: 88] [Article Influence: 7.9] [Reference Citation Analysis]
38 Serhan CN, Chiang N, Dalli J. Macrophages and the Entrance of Resolution Phase Lipid Mediators. In: Biswas SK, Mantovani A, editors. Macrophages: Biology and Role in the Pathology of Diseases. New York: Springer; 2014. pp. 287-314. [DOI: 10.1007/978-1-4939-1311-4_13] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
39 Das A, Roy S. Micromanaging Inflammation and Tissue Repair. MicroRNA in Regenerative Medicine. Elsevier; 2015. pp. 739-56. [DOI: 10.1016/b978-0-12-405544-5.00028-9] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
40 Russell FD, Bürgin-Maunder CS. Distinguishing health benefits of eicosapentaenoic and docosahexaenoic acids. Mar Drugs 2012;10:2535-59. [PMID: 23203276 DOI: 10.3390/md10112535] [Cited by in Crossref: 55] [Cited by in F6Publishing: 44] [Article Influence: 5.5] [Reference Citation Analysis]
41 Prüss H, Kopp MA, Brommer B, Gatzemeier N, Laginha I, Dirnagl U, Schwab JM. Non-resolving aspects of acute inflammation after spinal cord injury (SCI): indices and resolution plateau. Brain Pathol 2011;21:652-60. [PMID: 21418368 DOI: 10.1111/j.1750-3639.2011.00488.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 60] [Article Influence: 5.6] [Reference Citation Analysis]
42 Carion TW, Greenwood M, Ebrahim AS, Jerome A, Suvas S, Gronert K, Berger EA. Immunoregulatory role of 15-lipoxygenase in the pathogenesis of bacterial keratitis. FASEB J 2018;32:5026-38. [PMID: 29913556 DOI: 10.1096/fj.201701502R] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
43 Serhan CN, Chiang N. Resolution phase lipid mediators of inflammation: agonists of resolution. Curr Opin Pharmacol 2013;13:632-40. [PMID: 23747022 DOI: 10.1016/j.coph.2013.05.012] [Cited by in Crossref: 201] [Cited by in F6Publishing: 190] [Article Influence: 22.3] [Reference Citation Analysis]
44 Van Dyke TE. Control of inflammation and periodontitis. Periodontol 2000. 2007;45:158-166. [PMID: 17850455 DOI: 10.1111/j.1600-0757.2007.00229.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 3.5] [Reference Citation Analysis]
45 Colas RA, Shinohara M, Dalli J, Chiang N, Serhan CN. Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue. Am J Physiol Cell Physiol 2014;307:C39-54. [PMID: 24696140 DOI: 10.1152/ajpcell.00024.2014] [Cited by in Crossref: 276] [Cited by in F6Publishing: 268] [Article Influence: 34.5] [Reference Citation Analysis]
46 Batool F, Stutz C, Petit C, Benkirane-Jessel N, Delpy E, Zal F, Leize-Zal E, Huck O. A therapeutic oxygen carrier isolated from Arenicola marina decreased P. gingivalis induced inflammation and tissue destruction. Sci Rep 2020;10:14745. [PMID: 32901057 DOI: 10.1038/s41598-020-71593-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
47 Bogie JF, Haidar M, Kooij G, Hendriks JJ. Fatty acid metabolism in the progression and resolution of CNS disorders. Advanced Drug Delivery Reviews 2020;159:198-213. [DOI: 10.1016/j.addr.2020.01.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
48 Recchiuti A, Serhan CN. Pro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in Inflammation. Front Immunol. 2012;3:298. [PMID: 23093949 DOI: 10.3389/fimmu.2012.00298] [Cited by in Crossref: 81] [Cited by in F6Publishing: 78] [Article Influence: 8.1] [Reference Citation Analysis]
49 Mclennan PL. Cardiac physiology and clinical efficacy of dietary fish oil clarified through cellular mechanisms of omega-3 polyunsaturated fatty acids. Eur J Appl Physiol 2014;114:1333-56. [DOI: 10.1007/s00421-014-2876-z] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 5.4] [Reference Citation Analysis]
50 Farooqui AA, Ong WY, Horrocks LA, Chen P, Farooqui T. Comparison of biochemical effects of statins and fish oil in brain: the battle of the titans. Brain Res Rev 2007;56:443-71. [PMID: 17959252 DOI: 10.1016/j.brainresrev.2007.09.004] [Cited by in Crossref: 72] [Cited by in F6Publishing: 43] [Article Influence: 4.8] [Reference Citation Analysis]
51 Qu Q, Xuan W, Fan GH. Roles of resolvins in the resolution of acute inflammation. Cell Biol Int 2015;39:3-22. [PMID: 25052386 DOI: 10.1002/cbin.10345] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
52 Freire MO, Van Dyke TE. Natural resolution of inflammation. Periodontol 2000 2013;63:149-64. [PMID: 23931059 DOI: 10.1111/prd.12034] [Cited by in Crossref: 169] [Cited by in F6Publishing: 153] [Article Influence: 24.1] [Reference Citation Analysis]
53 Horta AL, Williams T, Han B, Ma Y, Menezes APJ, Tu V, Talvani A, Weiss LM, Huang H. Resolvin D1 Administration Is Beneficial in Trypanosoma cruzi Infection. Infect Immun 2020;88:e00052-20. [PMID: 32152197 DOI: 10.1128/IAI.00052-20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Hansen TV, Vik A, Serhan CN. The Protectin Family of Specialized Pro-resolving Mediators: Potent Immunoresolvents Enabling Innovative Approaches to Target Obesity and Diabetes. Front Pharmacol 2018;9:1582. [PMID: 30705632 DOI: 10.3389/fphar.2018.01582] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 12.0] [Reference Citation Analysis]
55 Baker LA, Martin NRW, Kimber MC, Pritchard GJ, Lindley MR, Lewis MP. Resolvin E1 (R v E 1 ) attenuates LPS induced inflammation and subsequent atrophy in C2C12 myotubes. J Cell Biochem 2018;119:6094-103. [DOI: 10.1002/jcb.26807] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
56 Zuber C, Taatjes DJ, Roth J. Recent progress in histochemistry. Histochem Cell Biol 2007;128:557-94. [PMID: 17972094 DOI: 10.1007/s00418-007-0350-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
57 Dondoni L, Scarparo RK, Kantarci A, Van Dyke TE, Figueiredo JA, Batista EL Jr. Effect of the pro-resolution lipid mediator Resolvin E1 (RvE1) on pulp tissues exposed to the oral environment. Int Endod J 2014;47:827-34. [PMID: 24298979 DOI: 10.1111/iej.12224] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
58 Navarini L, Bisogno T, Margiotta DPE, Piccoli A, Angeletti S, Laudisio A, Ciccozzi M, Afeltra A, Maccarrone M. Role of the Specialized Proresolving Mediator Resolvin D1 in Systemic Lupus Erythematosus: Preliminary Results. J Immunol Res 2018;2018:5264195. [PMID: 30420970 DOI: 10.1155/2018/5264195] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
59 Taatjes DJ, Zuber C, Roth J. The histochemistry and cell biology vade mecum: a review of 2005–2006. Histochem Cell Biol 2006;126:743-88. [DOI: 10.1007/s00418-006-0253-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
60 Serhan CN. Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not? Am J Pathol 2010;177:1576-91. [PMID: 20813960 DOI: 10.2353/ajpath.2010.100322] [Cited by in Crossref: 289] [Cited by in F6Publishing: 266] [Article Influence: 24.1] [Reference Citation Analysis]
61 Hasturk H, Kantarci A, Van Dyke TE. Paradigm shift in the pharmacological management of periodontal diseases. Front Oral Biol 2012;15:160-76. [PMID: 22142963 DOI: 10.1159/000329678] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 4.1] [Reference Citation Analysis]
62 Clària J, Dalli J, Yacoubian S, Gao F, Serhan CN. Resolvin D1 and resolvin D2 govern local inflammatory tone in obese fat. J Immunol 2012;189:2597-605. [PMID: 22844113 DOI: 10.4049/jimmunol.1201272] [Cited by in Crossref: 155] [Cited by in F6Publishing: 154] [Article Influence: 15.5] [Reference Citation Analysis]
63 de Freitas DDN, Marinho Franceschina C, Muller D, Hilario GT, Gassen RB, Fazolo T, de Lima Kaminski V, Bogo Chies JA, Maito F, Antunes KH, Zanin RF, Rodrigues LC Jr, Duarte de Souza AP. RvD1 treatment during primary infection modulates memory response increasing viral load during respiratory viral reinfection. Immunobiology 2021;226:152151. [PMID: 34742024 DOI: 10.1016/j.imbio.2021.152151] [Reference Citation Analysis]
64 Ariel A, Serhan CN. Resolvins and protectins in the termination program of acute inflammation. Trends Immunol. 2007;28:176-183. [PMID: 17337246 DOI: 10.1016/j.it.2007.02.007] [Cited by in Crossref: 241] [Cited by in F6Publishing: 224] [Article Influence: 16.1] [Reference Citation Analysis]
65 Fredman G, Li Y, Dalli J, Chiang N, Serhan CN. Self-limited versus delayed resolution of acute inflammation: temporal regulation of pro-resolving mediators and microRNA. Sci Rep 2012;2:639. [PMID: 22957142 DOI: 10.1038/srep00639] [Cited by in Crossref: 85] [Cited by in F6Publishing: 78] [Article Influence: 8.5] [Reference Citation Analysis]
66 Hasturk H, Schulte F, Martins M, Sherzai H, Floros C, Cugini M, Chiu CJ, Hardt M, Van Dyke T. Safety and Preliminary Efficacy of a Novel Host-Modulatory Therapy for Reducing Gingival Inflammation. Front Immunol 2021;12:704163. [PMID: 34589083 DOI: 10.3389/fimmu.2021.704163] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
67 Wolfer AM, Gaudin M, Taylor-Robinson SD, Holmes E, Nicholson JK. Development and Validation of a High-Throughput Ultrahigh-Performance Liquid Chromatography-Mass Spectrometry Approach for Screening of Oxylipins and Their Precursors. Anal Chem 2015;87:11721-31. [PMID: 26501362 DOI: 10.1021/acs.analchem.5b02794] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 4.9] [Reference Citation Analysis]
68 Kadl A, Leitinger N. The role of endothelial cells in the resolution of acute inflammation. Antioxid Redox Signal 2005;7:1744-54. [PMID: 16356135 DOI: 10.1089/ars.2005.7.1744] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 3.0] [Reference Citation Analysis]
69 Abdolmaleki F, Kovanen PT, Mardani R, Gheibi-Hayat SM, Bo S, Sahebkar A. Resolvins: Emerging Players in Autoimmune and Inflammatory Diseases. Clin Rev Allergy Immunol 2020;58:82-91. [PMID: 31267470 DOI: 10.1007/s12016-019-08754-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
70 Pascoal LB, Palma BB, Chaim FHM, de Castro MM, Damázio TA, Franceschini APMF, Milanski M, Velloso LA, Leal RF. New translational and experimental insights into the role of pro-resolving lipid mediators in inflammatory bowel disease. World J Exp Med 2022; 12(1): 1-15 [DOI: 10.5493/wjem.v12.i1.1] [Reference Citation Analysis]
71 Wang Q, Yan SF, Hao Y, Jin SW. Specialized Pro-resolving Mediators Regulate Alveolar Fluid Clearance during Acute Respiratory Distress Syndrome. Chin Med J (Engl) 2018;131:982-9. [PMID: 29664060 DOI: 10.4103/0366-6999.229890] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
72 Ariel A, Fredman G, Sun YP, Kantarci A, Van Dyke TE, Luster AD, Serhan CN. Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression. Nat Immunol. 2006;7:1209-1216. [PMID: 17013391 DOI: 10.1038/ni1392] [Cited by in Crossref: 234] [Cited by in F6Publishing: 231] [Article Influence: 14.6] [Reference Citation Analysis]
73 Serhan CN, Chiang N, Dalli J, Levy BD. Lipid mediators in the resolution of inflammation. Cold Spring Harb Perspect Biol. 2015;7:a016311. [PMID: 25359497 DOI: 10.1101/cshperspect.a016311] [Cited by in Crossref: 218] [Cited by in F6Publishing: 208] [Article Influence: 27.3] [Reference Citation Analysis]
74 Schif-Zuck S, Gross N, Assi S, Rostoker R, Serhan CN, Ariel A. Saturated-efferocytosis generates pro-resolving CD11b low macrophages: modulation by resolvins and glucocorticoids. Eur J Immunol 2011;41:366-79. [PMID: 21268007 DOI: 10.1002/eji.201040801] [Cited by in Crossref: 159] [Cited by in F6Publishing: 165] [Article Influence: 13.3] [Reference Citation Analysis]
75 Mittal A, Ranganath V, Nichani A. Omega fatty acids and resolution of inflammation: A new twist in an old tale. J Indian Soc Periodontol 2010;14:3-7. [PMID: 20922071 DOI: 10.4103/0972-124X.65426] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
76 Gilroy D, Lawrence T. The resolution of acute inflammation: A ‘tipping point’ in the development of chronic inflammatory diseases. In: Rossi AG, Sawatzky DA, editors. The Resolution of Inflammation. Basel: Birkhäuser; 2008. pp. 1-18. [DOI: 10.1007/978-3-7643-7506-5_1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
77 Romano M, Cianci E, Simiele F, Recchiuti A. Lipoxins and aspirin-triggered lipoxins in resolution of inflammation. European Journal of Pharmacology 2015;760:49-63. [DOI: 10.1016/j.ejphar.2015.03.083] [Cited by in Crossref: 88] [Cited by in F6Publishing: 89] [Article Influence: 12.6] [Reference Citation Analysis]
78 Transler C, Mitchell S, Eilander A. Could Polyunsaturated Fatty Acids Deficiency Explain Some Dysfunctions Found in ADHD? Hypotheses From Animal Research. J Atten Disord 2013;17:20-8. [DOI: 10.1177/1087054711401345] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
79 Dong L, Li Y, Wu H. Platelet activating-factor acetylhydrolase II: A member of phospholipase A2 family that hydrolyzes oxidized phospholipids. Chem Phys Lipids 2021;239:105103. [PMID: 34116047 DOI: 10.1016/j.chemphyslip.2021.105103] [Reference Citation Analysis]
80 Bhela S, Rouse BT. Are miRNAs critical determinants in herpes simplex virus pathogenesis? Microbes Infect 2018;20:461-5. [PMID: 29287990 DOI: 10.1016/j.micinf.2017.12.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
81 Shoieb SM, El-Ghiaty MA, El-Kadi AOS. Targeting arachidonic acid-related metabolites in COVID-19 patients: potential use of drug-loaded nanoparticles. Emergent Mater 2020;:1-13. [PMID: 33225219 DOI: 10.1007/s42247-020-00136-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
82 Wohlers M, Xavier RA, Oyama LM, Ribeiro EB, do Nascimento CM, Casarini DE, Silveira VL. Effect of fish or soybean oil-rich diets on bradykinin, kallikrein, nitric oxide, leptin, corticosterone and macrophages in carrageenan stimulated rats. Inflammation 2005;29:81-9. [PMID: 16897355 DOI: 10.1007/s10753-006-9002-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
83 Dalli J, Colas RA, Serhan CN. Novel n-3 immunoresolvents: structures and actions. Sci Rep 2013;3:1940. [PMID: 23736886 DOI: 10.1038/srep01940] [Cited by in Crossref: 144] [Cited by in F6Publishing: 127] [Article Influence: 16.0] [Reference Citation Analysis]
84 Kantarci A, Hasturk H, Van Dyke TE. Host-mediated resolution of inflammation in periodontal diseases. Periodontol 2000. 2006;40:144-163. [PMID: 16398691 DOI: 10.1111/j.1600-0757.2005.00145.x] [Cited by in Crossref: 70] [Cited by in F6Publishing: 64] [Article Influence: 4.4] [Reference Citation Analysis]
85 Aubin É, Lemieux R, Bazin R. Absence of cytokine modulation following therapeutic infusion of intravenous immunoglobulin or anti-red blood cell antibodies in a mouse model of immune thrombocytopenic purpura. Br J Haematol 2007;136:837-43. [DOI: 10.1111/j.1365-2141.2007.06495.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
86 Hasturk H, Kantarci A, Goguet-Surmenian E, Blackwood A, Andry C, Serhan CN, Van Dyke TE. Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo. J Immunol. 2007;179:7021-7029. [PMID: 17982093 DOI: 10.4049/jimmunol.179.10.7021] [Cited by in Crossref: 282] [Cited by in F6Publishing: 264] [Article Influence: 18.8] [Reference Citation Analysis]
87 Nourshargh S, Marelli-Berg FM. Transmigration through venular walls: a key regulator of leukocyte phenotype and function. Trends Immunol 2005;26:157-65. [PMID: 15745858 DOI: 10.1016/j.it.2005.01.006] [Cited by in Crossref: 106] [Cited by in F6Publishing: 100] [Article Influence: 6.2] [Reference Citation Analysis]
88 Kalsotra A, Anakk S, Brommer CL, Kikuta Y, Morgan ET, Strobel HW. Catalytic characterization and cytokine mediated regulation of cytochrome P450 4Fs in rat hepatocytes. Arch Biochem Biophys 2007;461:104-12. [PMID: 17418803 DOI: 10.1016/j.abb.2007.02.027] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
89 Pugliese A, Vidotto V, Beltramo T, Torre D. Phagocytic activity in human immunodeficiency virus type 1 infection. Clin Diagn Lab Immunol 2005;12:889-95. [PMID: 16085904 DOI: 10.1128/CDLI.12.8.889-895.2005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
90 D'Souza El-Guindy NB, de Villiers WJ, Doherty DE. Acute alcohol intake impairs lung inflammation by changing pro- and anti-inflammatory mediator balance. Alcohol 2007;41:335-45. [PMID: 17889310 DOI: 10.1016/j.alcohol.2007.07.002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
91 Serhan CN, Dalli J, Colas RA, Winkler JW, Chiang N. Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome. Biochim Biophys Acta. 2015;1851:397-413. [PMID: 25139562 DOI: 10.1016/j.bbalip.2014.08.006] [Cited by in Crossref: 244] [Cited by in F6Publishing: 227] [Article Influence: 30.5] [Reference Citation Analysis]
92 Serhan CN, Gotlinger K, Hong S, Lu Y, Siegelman J, Baer T, Yang R, Colgan SP, Petasis NA. Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes. J Immunol 2006;176:1848-59. [PMID: 16424216 DOI: 10.4049/jimmunol.176.3.1848] [Cited by in Crossref: 318] [Cited by in F6Publishing: 297] [Article Influence: 19.9] [Reference Citation Analysis]
93 Avanoǧlu Güler A, Rossi FW, Bellando-Randone S, Prevete N, Tufan A, Manetti M, de Paulis A, Matucci-Cerinic M. The Role of Endogenous Eicosapentaenoic Acid and Docosahexaenoic Acid-Derived Resolvins in Systemic Sclerosis. Front Immunol 2020;11:1249. [PMID: 32636845 DOI: 10.3389/fimmu.2020.01249] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
94 Sur B, Lee B, Yeom M, Han J, Choi H, Lee H, Kim SJ, Yoon SH, Hahm D. Inhibitory effect of phosphatidylserine on atopy-like dermatitis in NC/Nga mice. Food Sci Biotechnol 2010;19:1513-8. [DOI: 10.1007/s10068-010-0215-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
95 Kompauer I, Demmelmair H, Koletzko B, Bolte G, Linseisen J, Heinrich J. Association of fatty acids in serum phospholipids with lung function and bronchial hyperresponsiveness in adults. Eur J Epidemiol 2008;23:175-90. [PMID: 18204906 DOI: 10.1007/s10654-007-9218-y] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 2.6] [Reference Citation Analysis]
96 Carion TW, Kracht D, Strand E, David E, McWhirter C, Ebrahim AS, Berger EA. VIP modulates the ALX/FPR2 receptor axis toward inflammation resolution in a mouse model of bacterial keratitis. Prostaglandins Other Lipid Mediat 2019;140:18-25. [PMID: 30529189 DOI: 10.1016/j.prostaglandins.2018.12.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
97 Taatjes DJ, Roth J. Recent progress in histochemistry and cell biology: the state of the art 2005. Histochem Cell Biol 2005;124:547-74. [PMID: 16283358 DOI: 10.1007/s00418-005-0110-0] [Reference Citation Analysis]
98 Panigrahy D, Gilligan MM, Serhan CN, Kashfi K. Resolution of inflammation: An organizing principle in biology and medicine. Pharmacol Ther 2021;:107879. [PMID: 33915177 DOI: 10.1016/j.pharmthera.2021.107879] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
99 Dos Santos HT, Nam K, Hunt JP, Buchmann LO, Monroe MM, Baker OJ. SPM Receptor Expression and Localization in Irradiated Salivary Glands. J Histochem Cytochem 2021;69:523-34. [PMID: 34339312 DOI: 10.1369/00221554211031678] [Reference Citation Analysis]
100 Serhan CN, Brain SD, Buckley CD, Gilroy DW, Haslett C, O’Neill LA, Perretti M, Rossi AG, Wallace JL. Resolution of inflammation: state of the art, definitions and terms. FASEB J. 2007;21:325-332. [PMID: 17267386 DOI: 10.1096/fj.06-7227rev] [Cited by in Crossref: 719] [Cited by in F6Publishing: 693] [Article Influence: 47.9] [Reference Citation Analysis]
101 Trivedi SG, Newson J, Rajakariar R, Jacques TS, Hannon R, Kanaoka Y, Eguchi N, Colville-Nash P, Gilroy DW. Essential role for hematopoietic prostaglandin D2 synthase in the control of delayed type hypersensitivity. Proc Natl Acad Sci U S A 2006;103:5179-84. [PMID: 16547141 DOI: 10.1073/pnas.0507175103] [Cited by in Crossref: 99] [Cited by in F6Publishing: 97] [Article Influence: 6.2] [Reference Citation Analysis]
102 Abeles AM, Pillinger MH, Abramson SB. Inflammation. Rheumatology. Elsevier; 2011. pp. 183-198.e2. [DOI: 10.1016/b978-0-323-06551-1.00021-x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
103 Tan JL, Tan YZ, Muljadi R, Chan ST, Lau SN, Mockler JC, Wallace EM, Lim R. Amnion Epithelial Cells Promote Lung Repair via Lipoxin A4. Stem Cells Transl Med 2017;6:1085-95. [PMID: 28371562 DOI: 10.5966/sctm.2016-0077] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
104 Lawrence T, Gilroy DW. Chronic inflammation: a failure of resolution? Int J Exp Pathol 2007;88:85-94. [PMID: 17408451 DOI: 10.1111/j.1365-2613.2006.00507.x] [Cited by in Crossref: 182] [Cited by in F6Publishing: 172] [Article Influence: 12.1] [Reference Citation Analysis]
105 Buckley CD, Gilroy DW, Serhan CN, Stockinger B, Tak PP. The resolution of inflammation. Nat Rev Immunol 2013;13:59-66. [PMID: 23197111 DOI: 10.1038/nri3362] [Cited by in Crossref: 312] [Cited by in F6Publishing: 204] [Article Influence: 31.2] [Reference Citation Analysis]
106 Souza DG, Fagundes CT, Amaral FA, Cisalpino D, Sousa LP, Vieira AT, Pinho V, Nicoli JR, Vieira LQ, Fierro IM, Teixeira MM. The required role of endogenously produced lipoxin A4 and annexin-1 for the production of IL-10 and inflammatory hyporesponsiveness in mice. J Immunol 2007;179:8533-43. [PMID: 18056401 DOI: 10.4049/jimmunol.179.12.8533] [Cited by in Crossref: 100] [Cited by in F6Publishing: 95] [Article Influence: 7.1] [Reference Citation Analysis]
107 Gilroy DW. The endogenous control of acute inflammation – from onset to resolution. Drug Discovery Today: Therapeutic Strategies 2004;1:313-9. [DOI: 10.1016/j.ddstr.2004.11.017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
108 Hasturk H, Goguet-surmenian E, Blackwood A, Andry C, Kantarci A. 1-Tetradecanol Complex: Therapeutic Actions in Experimental Periodontitis. Journal of Periodontology 2009;80:1103-13. [DOI: 10.1902/jop.2009.090002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
109 Hirano T, Murakami T, Ono H, Sakurai A, Tominaga T, Takahashi T, Nagai K, Doi T, Abe H. A Novel Interaction between FLICE-Associated Huge Protein (FLASH) and E2A Regulates Cell Proliferation and Cellular Senescence via Tumor Necrosis Factor (TNF)-Alpha-p21WAF1/CIP1 Axis. PLoS One 2015;10:e0133205. [PMID: 26208142 DOI: 10.1371/journal.pone.0133205] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]